Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PF-07247685
Cat. No.:
OB0425LY-410
Appearance:
Solid
Purity:
99.57%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
PF-07247685 is a BDK kinase inhibitor that functions in the cardiac metabolic system.
Synonyms:
PF-07247685; PF07247685; PF 07247685
Formula:
C21H20N2O3S
Formula Weight:
380.46
Specification
Target:
Endogenous metabolite
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO, Ethanol
Storage:
Storage at -20°C.
Applications:
PF-07247685 is involved in metabolic regulation and can be used in energy homeostasis and glucose metabolism research, with potential implications for diabetes treatment.
